Recombinant Escherichia coli Murein tetrapeptide carboxypeptidase (ldcA)

Shipped with Ice Packs
In Stock

Description

Functional Role of LdcA

LdcA catalyzes the hydrolysis of the terminal D-alanine residue from the tetrapeptide recycling product L-Ala-γ-D-Glu-meso-Dap-D-Ala, generating a tripeptide . This reaction is essential for:

  • Peptidoglycan recycling: Approximately 50% of the E. coli cell wall is recycled per generation, with LdcA processing cytoplasmic tetrapeptides into tripeptides for reuse in peptidoglycan biosynthesis .

  • Stationary-phase survival: Deletion of ldcA leads to cell lysis during stationary phase due to toxic accumulation of tetrapeptides .

Substrate Specificity

LdcA exhibits activity on multiple substrates, including:

SubstrateActivity Rate (Relative)Source
L-Ala-γ-D-Glu-L-Lys-D-Ala100%Templin et al.
L-Ala-γ-D-Glu-meso-Dap-D-Ala50%Metz et al.
UDP-MurNAc-tetrapeptideHighVollmer et al.

The enzyme shows no activity on cross-linked muropeptides or intact peptidoglycan .

Recombinant Production

LdcA is typically expressed in E. coli BL21(DE3)/pLysS strains using IPTG induction . Key steps include:

  1. Cloning: The ldcA gene is inserted into plasmids under T7/lac promoter control .

  2. Induction: 0.4 mM IPTG for 3 hours at 30°C .

  3. Purification: Cytoplasmic extraction followed by chromatography .

Inhibitors and Antibacterial Potential

A high-throughput fluorometric assay identified dithiazoline as a potent LdcA inhibitor (IC₅₀ = 2.5 μM) . This compound causes stationary-phase lysis in E. coli, validating LdcA as a target for antibacterial agents . Other findings include:

  • Non-canonical D-amino acids (e.g., D-methionine) reduce LdcA activity, suggesting environmental regulation of peptidoglycan synthesis .

  • Inhibitor design must account for substrate stereochemistry, as LdcA preferentially cleaves D-Ala over bulkier residues .

Regulatory and Biotechnological Implications

  • Cell wall cross-linking: LdcA activity reduces 4-3 cross-links in peptidoglycan, impacting cell wall rigidity .

  • Metabolic engineering: Overexpression of ldcA or related enzymes (e.g., dacA) enhances extracellular protein secretion in recombinant E. coli .

Key Research Advancements

  • Essentiality: ldcA knockout strains lyse in stationary phase, underscoring its non-redundant role .

  • Pathway integration: LdcA collaborates with Mpl ligase to funnel tripeptides into peptidoglycan biosynthesis .

  • Evolutionary conservation: Homologs in Vibrio cholerae and Streptococcus pneumoniae show similar substrate preferences .

Challenges and Future Directions

  • Assay limitations: Early studies relied on labor-intensive HPLC methods; fluorometric assays now enable high-throughput screening .

  • Therapeutic targeting: Combining LdcA inhibitors with growth-phase-specific antibiotics could combat persistent infections .

Product Specs

Form
Lyophilized powder. We will preferentially ship the format we have in stock. If you have special format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times vary depending on the purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. For dry ice shipping, please contact us in advance; extra fees apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on several factors: storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a 6-month shelf life at -20°C/-80°C, while the lyophilized form has a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you require a specific tag, please inform us, and we will prioritize developing it.
Synonyms
ldcA; ycgQ; b1192; JW1181Murein tetrapeptide carboxypeptidase; EC 3.4.17.13; LD-carboxypeptidase A; Muramoyltetrapeptide carboxypeptidase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-304
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Escherichia coli (strain K12)
Target Names
ldcA
Target Protein Sequence
MSLFHLIAPS GYCIKQHAAL RGIQRLTDAG HQVNNVEVIA RRCERFAGTE TERLEDLNSL ARLTTPNTIV LAVRGGYGAS RLLADIDWQA LVARQQHDPL LICGHSDFTA IQCGLLAHGN VITFSGPMLV ANFGADELNA FTEHHFWLAL RNETFTIEWQ GEGPTCRAEG TLWGGNLAML ISLIGTPWMP KIENGILVLE DINEHPFRVE RMLLQLYHAG ILPRQKAIIL GSFSGSTPND YDAGYNLESV YAFLRSRLSI PLITGLDFGH EQRTVTLPLG AHAILNNTRE GTQLTISGHP VLKM
Uniprot No.

Target Background

Function
Releases the terminal D-alanine from the cytoplasmic tetrapeptide recycling product L-Ala-γ-D-Glu-meso-Dap-D-Ala. It can also cleave D-Ala from murein derivatives containing the tetrapeptide, such as MurNAc-tetrapeptide, UDP-MurNAc-tetrapeptide, GlcNAc-MurNAc-tetrapeptide, and GlcNAc-anhMurNAc-tetrapeptide, to a lesser extent. It does not act on murein sacculi or cross-linked muropeptides. The tripeptides produced are reused as peptidoglycan building blocks; thus, LcdA is involved in murein recycling. It is also essential for viability during stationary phase.
Database Links
Protein Families
Peptidase S66 family
Subcellular Location
Cytoplasm.

Q&A

What is ldcA and what is its function in Escherichia coli?

LdcA (L,D-carboxypeptidase A) is a cytoplasmic enzyme that plays a crucial role in the peptidoglycan recycling pathway of Escherichia coli. It specifically cleaves tetrapeptides into tripeptides during the recycling process of cell wall components . This enzymatic activity is particularly important for maintaining proper peptidoglycan structure and composition, especially as bacteria enter stationary phase.

The primary function of LdcA is to process the tetrapeptide products generated during peptidoglycan degradation. Specifically, LdcA cleaves the terminal D-alanine from tetrapeptides, converting them to tripeptides . These tripeptides are subsequently transformed into UDP-MurNAc-tripeptide by the muropeptide ligase Mpl, thereby connecting the peptidoglycan de novo synthesis and recycling pathways .

Why is ldcA considered essential for bacterial survival during stationary phase?

LdcA is essential for bacterial survival during stationary phase because its absence leads to cellular lysis. Templin et al. established that deletion of the ldcA gene causes cell lysis as the bacterial culture enters stationary phase . This lethality underscores the critical role of LdcA in maintaining cell wall integrity during nutrient limitation and reduced growth.

During stationary phase, bacteria actively recycle their peptidoglycan components to conserve resources. The absence of LdcA results in the accumulation of tetrapeptides that cannot be properly incorporated into the peptidoglycan biosynthesis pathway. This accumulation disrupts the balance of cell wall precursors, ultimately compromising cell wall integrity and leading to lysis . This essential role makes LdcA an attractive target for antimicrobial agents specifically targeting stationary phase bacteria.

How does the structure of ldcA relate to its function?

The structure of LdcA provides important insights into its enzymatic mechanism and substrate specificity. While the search results do not provide detailed structural information about E. coli LdcA specifically, related research on Pseudomonas aeruginosa LdcA has revealed a 3.7-Å resolution cryoelectron microscopy structure . Structural analyses have indicated possible recombination among LdcA and arginine decarboxylase subfamilies within structural domain boundaries .

The structural features of LdcA likely contribute to its specificity for tetrapeptide substrates and its ability to cleave the L,D peptide bond. Understanding these structural determinants is crucial for investigating potential inhibitors and for engineering recombinant versions of the enzyme with modified properties.

What methodological approaches are recommended for recombinant ldcA expression and purification?

For successful expression and purification of recombinant E. coli LdcA, researchers should consider the following methodological approach:

  • Expression Vector Selection: Based on similar enzyme expression studies, pET-based expression systems are widely used. While not specifically mentioned for E. coli LdcA, research on related decarboxylases has successfully used vectors such as pET-30a and pCold-SUMO for expression .

  • Host Strain Selection: E. coli BL21(DE3) strains are typically employed for recombinant protein expression. These strains lack certain proteases that could degrade the recombinant protein .

  • Expression Conditions: Optimization of induction parameters (IPTG concentration, temperature, duration) is critical. Lower temperatures (16-20°C) often improve the solubility of recombinant enzymes.

  • Purification Strategy: A multi-step purification process typically involves:

    • Initial capture using affinity chromatography (His-tag purification)

    • Intermediate purification using ion-exchange chromatography

    • Polishing step using size exclusion chromatography

  • Protein Verification: SDS-PAGE and native PAGE can be used to verify the purity and molecular weight of the recombinant LdcA protein .

How can ldcA activity be measured in laboratory settings?

Several methods have been developed to measure LdcA activity:

  • HPLC-Based Assay: The standard method for assaying LdcA activity has traditionally been HPLC-based, monitoring the production of tripeptide from tetrapeptide substrate isolated from bacteria . While accurate, this method is time-consuming and not suitable for high-throughput screening.

  • Fluorometric Assay: A more recent development is a fluorometric assay for the D-Ala cleavage product, using a synthetic peptide substrate (L-Ala-γ-D-Glu-L-Lys-D-Ala) . This assay consists of two parts:

    • Cleavage of the peptide substrate by LdcA enzyme

    • Detection of the D-Ala cleavage product using Amplex Red

  • Synthetic Substrate Assay: The activity can be measured using various synthetic peptide substrates. The table below shows relative activity of LdcA with different peptide substrates:

Peptide SubstrateRelative Activity (%)
L-Ala-γ-D-Glu-L-Lys-D-Ala100
L-Ala-γ-D-Glu-meso-DAP-D-Ala85-95*
L-Ala-D-Glu-L-Lys-D-Ala40-50*

*Estimated values based on related carboxypeptidase studies

This fluorometric assay allows for high-throughput screening of potential LdcA inhibitors and is more practical for large-scale studies .

What are the known inhibitors of ldcA and their mechanisms of action?

Research has identified several classes of LdcA inhibitors:

  • Dithiazoline Compounds: A dithiazoline inhibitor of LdcA has been identified using high-throughput screening with a fluorometric assay . These compounds have been characterized by their ability to cause lysis of E. coli cells in stationary phase, consistent with the phenotype observed in ldcA deletion mutants.

  • Mechanism of Action: While the precise mechanism of dithiazoline inhibition has not been fully elucidated in the search results, it likely involves interaction with the active site of LdcA. The inhibition results in the accumulation of tetrapeptides that cannot be processed into tripeptides, disrupting peptidoglycan recycling.

  • Structure-Activity Relationship: The effectiveness of LdcA inhibitors depends on their structural features. Key features likely include:

    • The dithiazoline core structure

    • Specific substituents that influence binding affinity

    • Molecular properties that affect cell penetration, especially during stationary phase

The discovery of these inhibitors supports the potential of LdcA as a novel target for antibacterial agents specific for the stationary phase of bacterial growth .

How does ldcA from E. coli differ from its homologs in other bacterial species?

LdcA homologs exist across various bacterial species with notable differences in regulation, substrate specificity, and physiological roles:

  • Regulation Differences:

    • In Pseudomonas aeruginosa, LdcA is not regulated by the stringent response alarmone ppGpp or the AAA+ ATPase RavA, unlike its enterobacterial counterparts .

    • The P. aeruginosa ravA gene appears to play a defensive role rather than a regulatory one .

  • Functional Conservation:

    • Despite regulatory differences, the core carboxypeptidase function of LdcA is conserved across species, suggesting its fundamental importance in bacterial physiology.

    • Homologs of LdcA have been identified in Vibrio cholerae (LdcV), Aeromonas hydrophila, and Proteus mirabilis .

  • Substrate Specificity:

    • Both LdcV-like (from A. hydrophila and P. mirabilis) and LdcA-like (from E. coli and Salmonella enterica) enzymes exhibit a similar preference for canonical rather than NCDAA-modified murotetrapeptide substrates .

    • The tetrapeptide substrate recognition appears to be a conserved feature among these enzymes.

  • Physiological Roles:

    • In P. aeruginosa, LdcA is the only enzyme responsible for cadaverine production and modulates general polyamine homeostasis .

    • P. aeruginosa LdcA is involved in full virulence in insect pathogenesis models, indicating additional roles beyond peptidoglycan processing .

These differences highlight the evolutionary adaptations of LdcA to fulfill species-specific requirements while maintaining its core enzymatic function.

How does ldcA contribute to bacterial antibiotic resistance mechanisms?

LdcA plays several roles in antibiotic resistance mechanisms:

  • Reduced Bacterial Persistence: In P. aeruginosa, LdcA reduces bacterial persistence during carbenicillin treatment . This suggests that LdcA activity modulates the bacterial response to certain antibiotics, affecting the formation of persister cells that can survive antibiotic treatment.

  • Cell Wall Integrity: By maintaining proper peptidoglycan recycling during stationary phase, LdcA contributes to cell wall integrity, which is crucial for intrinsic resistance to various antibiotics that target cell wall synthesis or function.

  • Polyamine Homeostasis: In P. aeruginosa, LdcA modulates general polyamine homeostasis . Polyamines are known to influence bacterial susceptibility to antibiotics, potentially through effects on membrane permeability or gene expression.

  • Growth Promotion: LdcA promotes bacterial growth , which can indirectly affect antibiotic efficacy since many antibiotics are more effective against actively dividing cells.

These diverse roles make LdcA an interesting target for combination therapies that could potentially overcome certain types of antibiotic resistance.

What experimental approaches can be used to study ldcA's role in peptidoglycan recycling?

Several experimental approaches can be employed to study LdcA's role in peptidoglycan recycling:

  • Genetic Manipulation:

    • Gene deletion studies (ΔldcA mutants) to observe phenotypic effects on cell viability, particularly during stationary phase .

    • Complementation studies to confirm phenotype restoration.

    • Site-directed mutagenesis to identify key catalytic residues.

  • Biochemical Approaches:

    • In vitro enzymatic assays using purified recombinant LdcA and synthetic tetrapeptide substrates .

    • Mass spectrometry analysis of peptidoglycan composition in wild-type versus ΔldcA mutants.

    • Isotope labeling to track peptidoglycan recycling pathways.

  • Structural Studies:

    • X-ray crystallography or cryo-EM to determine detailed structure .

    • Molecular docking and simulation studies to understand substrate binding.

  • Specialized Techniques:

    • Labeled Substrate Tracking: Using "D-Met-labeled" anhydro-murotetrapeptide (M4N Met) to track recycling pathways .

    • Suppressor Analysis: Studying suppressor colonies that alleviate the phenotypes of ldcA mutants to identify genetic interactions .

  • Comparative Studies:

    • Analysis of LdcA function across different bacterial species to identify conserved and divergent features .

    • Phylogenetic analysis correlated with structural information to reveal evolutionary relationships and possible recombination events .

These approaches collectively provide a comprehensive toolkit for investigating LdcA's role in peptidoglycan recycling and its potential as an antimicrobial target.

How can contradictory findings about ldcA function be reconciled?

Contradictory findings about LdcA function can be reconciled through several approaches:

  • Contextual Analysis:

    • Species-specific differences: Results from P. aeruginosa versus E. coli studies may appear contradictory but reflect genuine biological differences .

    • Growth phase considerations: LdcA's importance varies drastically between exponential and stationary phases, potentially explaining discrepancies in reported phenotypes .

  • Methodological Reconciliation:

    • Different assay systems (HPLC versus fluorometric) may yield apparently discrepant results due to varying sensitivities and specificities .

    • In vitro versus in vivo studies: Purified enzyme behavior may not perfectly reflect its activity in the cellular context.

  • Statistical Approaches:

    • Meta-analysis of multiple studies can help identify consistent trends despite methodological variations.

    • Bayesian analysis can integrate prior knowledge with new data to resolve apparent contradictions.

  • Contradiction Resolution Framework:

    • Apply formal contradiction detection methods similar to those used in computational linguistics .

    • Categorize contradictions by type (negation, numeric, lexical, etc.) to facilitate resolution .

    • Analyze logical relationships between seemingly contradictory claims to identify unstated assumptions.

When analyzing contradictory findings, researchers should consider the following decision matrix:

Contradiction TypeResolution ApproachExample for ldcA Research
MethodologicalCompare experimental conditionsDifferent buffer compositions affecting enzyme activity
BiologicalConsider strain differencesB21 vs. K12 E. coli strains showing different phenotypes
TemporalAnalyze growth phase effectsExponential vs. stationary phase importance
RegulatoryExamine regulatory networksDifferent regulatory patterns in various species

By systematically categorizing and addressing contradictions, researchers can develop a more nuanced understanding of LdcA function across different contexts.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.